Letter to the Editor Regarding “Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis” - Poll - MDSpire

Letter to the Editor Regarding “Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis”

  • By

  • Kim Rand

  • Kurt Gebauer

  • Yousef Binamer

  • Yung-Tsu Cho

  • Manny Papadimitropoulos

  • Chao Yang

  • Helena Agell

  • Bülent Akmaz

  • Lucia Seminario-Vidal

  • June 26, 2026

  • 0 min

Share

Original Source(s)

Letter to the Editor Regarding “Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis”

  • by Kim Rand, Kurt Gebauer, Yousef Binamer, Yung-Tsu Cho, Manny Papadimitropoulos, Chao Yang, Helena Agell, Bülent Akmaz, Lucia Seminario-Vidal

  • June 26, 2026

Related Content

IL-17, IL-23 Therapies Lead Psoriasis Care

Network meta-analysis suggests higher PASI 90 response rates with biologics vs oral systemic therapies

Ivarmacitinib Eased Refractory PCA: Case Report

Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.

AAD Issues Pediatric Atopic Dermatitis Guidelines

Two companion guidelines provide 41 evidence-based recommendations on treatment and prevention, along with 29 statements on comorbidity associations in patients under 18